CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk› Healthcare› Eris Lifesciences Ltd

Eris Lifesciences Ltd

BSE 540596 ERIS INE406M01024
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals NIFTY 500

Filing rhythm · 60 trading days

18 filings · 4 material · busiest 2026-07-29

What it files

Analyst / Investor Meet6 General2 ESOP Allotment2 Concall Transcript1 Board Outcome1 Results1 Investor Presentation1 Board Meeting1

Filings

18 in the window

  1. 24 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    As Attached

    Company Update / Analyst / Investor Meet View filing →

  2. 12 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    as attached

    Company Update / Analyst / Investor Meet View filing →

  3. 10 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    As Attached

    Company Update / Analyst / Investor Meet View filing →

  4. 6 August 2026

    General

    Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015, - Availing Working Capital Term Loan From Axis Bank

    as attached

    Company Update / General View filing →

  5. 4 August 2026

    Concall Transcript

    Earnings Call Transcript

    As Attached

    Company Update / Earnings Call Transcript View filing →

  6. 30 July 2026

    ESOP Allotment

    Allotment of ESOP / ESPS

    As Attached

    Company Update / Allotment of ESOP / ESPS View filing →

  7. 30 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    As Attached

    Company Update / Analyst / Investor Meet View filing →

  8. 29 July 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting

    as attached

    Board Meeting / Outcome of Board Meeting View filing →

  9. 29 July 2026

    Results

    Financial Results For The Quarter Ended June 30, 2026

    as attached

    Result / Financial Results View filing →

  10. 29 July 2026

    Investor Presentation

    Investor Presentation

    as attached

    Company Update / Investor Presentation View filing →

  11. 29 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    As Attached

    Company Update / Analyst / Investor Meet View filing →

  12. 23 July 2026

    Board Meeting

    Board Meeting Intimation for Consideration And Approval Of The Financial Results For The Period Ended June 30, 2026

    Eris Lifesciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 ,inter alia, to consider and approve the financial results for ....

    Board Meeting / Board Meeting View filing →

  13. 23 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    As Attached

    Company Update / Analyst / Investor Meet View filing →

  14. 9 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    As attached

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  15. 26 June 2026

    ESOP Allotment

    Allotment of ESOP / ESPS

    as attached

    Company Update / Allotment of ESOP / ESPS View filing →

  16. 26 June 2026

    Trading Window

    Closure of Trading Window

    As attached

    Insider Trading / SAST / Closure of Trading Window View filing →

  17. 23 June 2026

    General

    Corporate Presentation

    as attached

    Company Update / General View filing →

  18. 8 June 2026

    NCD Certificate

    Compliances-Reg. 57 (1) - Certificate of interest payment/Principal in case of NCD

    As Attached

    Others / Reg. 57 (1) - Certificate of interest payment/Principal in case of NCD View filing →